Dopamine Agonists: How They Work, What They Treat, and Their Risks
Updated: 6 days ago
Written and medically reviewed by Dr. Baraa Alnahhal, MD · Last reviewed: October 2026 · How we review
Quick Answer: What are dopamine agonists?
Dopamine agonists are prescription medicines that activate dopamine receptors, so cells respond as if dopamine were present. They are a key treatment for Parkinson's disease and also treat restless legs syndrome and high prolactin. Common side effects include nausea and dizziness; long-term use can cause impulse control problems and sleep attacks. Never stop them suddenly. [1]
What the research says
Dopamine agonists raise the odds of impulse control disorders about two- to 3.5-fold. In 3,090 people with Parkinson's disease, 17.1% of those taking a dopamine agonist had an impulse control disorder, compared with 6.9% of those not taking one (odds ratio 2.72). (Weintraub et al., Archives of Neurology, 2010) [2]
Oral tablets carry a higher impulse-control risk than the skin patch. Pooled data from 658 patients showed impulse control disorders in 25.3% of people on pramipexole and 21.8% on ropinirole; compared with the rotigotine patch, the risk was about 3.5 and 3 times higher. (Soileau et al., Neurological Sciences, 2024) [3]
Stopping suddenly can cause withdrawal, and the risk stacks up. Of 126 people taken off a dopamine agonist, 16.8% developed withdrawal syndrome. The chance was 3% with no risk factors, 30% with one, 70% with two and 92% with all three. (Garcia et al., Clinical Parkinsonism & Related Disorders, 2022) [4]
Key takeaways
Dopamine agonists act on the same receptors as dopamine, the brain chemical behind movement, reward and learning. [1]
They treat Parkinson's disease, restless legs syndrome, high prolactin and several other conditions. [1]
Side effects become more common at higher doses and with longer use. [1]
Impulse control problems — gambling, shopping, binge eating, hypersexuality — are a known risk. [1][2]
Stopping or cutting the dose suddenly can trigger dopamine agonist withdrawal syndrome. [1][4]
What is a dopamine agonist?
A dopamine agonist is a drug that activates dopamine receptors, the "locks" on the surface of certain cells, in the same way dopamine does. [1]
Your nervous system communicates through chemicals called neurotransmitters. Think of them as keys. Each has a specific shape that fits a matching lock (receptor) on a cell and switches that cell on. [1][7]
Dopamine (pronounced "DOE-pah-meen") is one of your brain's most important neurotransmitters. It helps you learn and feel reward and pleasure. The brain areas that control muscle movement also need it to work properly. [1][8]
A dopamine agonist is not dopamine. But dopamine-sensitive cells cannot tell the difference, so they react to the drug the same way they react to dopamine. [1]
Why does dopamine matter outside the brain?
Dopamine also helps control your heart, kidneys, pancreas, pituitary gland, endocrine system, digestive system and reproductive system. [1] That is why low dopamine can affect many body systems — and why dopamine agonists treat conditions well beyond the brain.
What conditions do dopamine agonists treat?
Dopamine agonists treat conditions linked to too little dopamine activity, led by Parkinson's disease. They are approved for, or used off-label to treat: [1]
Condition | What it is |
Movement disorders causing slowness, stiffness and tremor | |
A strong urge to move the legs, mostly at night | |
Too much of the hormone prolactin in the blood | |
A rare, deadly reaction to certain antipsychotic drugs | |
Dangerously high blood pressure | |
Type 2 diabetes | High blood sugar from insulin resistance |
Amenorrhea and oligomenorrhea | No periods, or fewer than six to eight periods a year |
What are the types of dopamine agonists?
Dopamine agonists fall into two groups: older ergot-based drugs, made from a rye fungus called ergot, and newer non-ergot drugs. [1] Some are used mainly for brain conditions such as Parkinson's disease; others mainly for conditions outside the brain. [1]
Generic name | Group | U.S. brand names | Form |
Bromocriptine | Ergot | Cycloset®, Parlodel® | Capsule or tablet |
Cabergoline | Ergot | Generic only (Dostinex no longer sold in the U.S.) | Tablet |
Amantadine | Non-ergot | Gocovri®, Osmolex® | Extended-release capsule |
Apomorphine | Non-ergot | Apokyn®, Kynmobi® | Injection |
Fenoldopam | Non-ergot | Corlopam® | Injection |
Pramipexole | Non-ergot | Mirapex® | Oral tablet |
Ropinirole | Non-ergot | Generic only (Requip no longer sold in the U.S.) | Oral tablet |
Rotigotine | Non-ergot | Neupro® | Skin patch |
Ergot-based drugs are used less today. Only two remain in use in the U.S., partly because they raise the risk of scar-tissue (fibrosis) conditions. [1][6]
Dopamine agonist prescriptions are common: millions of people in the U.S. take one, most often for Parkinson's disease. [1]
What are the benefits of dopamine agonists?
Dopamine agonists are effective, treat a wide range of conditions and can lower the dose needed of other medicines. [1] The main benefits are:
Proven effectiveness. Research confirms they work well for many conditions. [1]
Wide range of uses. They hold U.S. approval for conditions from movement disorders to hormone problems that disrupt the menstrual cycle. [1]
Lower doses of other drugs. Taken with levodopa for Parkinson's disease, they let a lower levodopa dose work as well as a higher one. [1] See our guide to Parkinson's disease medications.
Life-saving potential. They can treat and reverse neuroleptic malignant syndrome. [1]
What are the side effects of dopamine agonists?
The most common side effects of dopamine agonists are digestive upset, dizziness and blood-pressure drops, and they become more likely as the dose goes up. [1] Long-term use can also change mood and behavior.
Physical side effects | Mental and behavioral changes (long-term use) |
Nausea and vomiting | Confusion |
Constipation | Depression |
Indigestion | Impulse control problems |
Headaches | Mania |
Dizziness | Psychosis-like symptoms (delusions, hallucinations) |
Orthostatic hypotension (lightheadedness or fainting on standing) | Sleep attacks and daytime sleepiness, especially with pramipexole and ropinirole |
Irregular heart rhythm (arrhythmia) | |
Uncontrolled, dance-like (chorea-like) movements |
What are impulse control problems from dopamine agonists?
Impulse control problems are compulsive behaviors a person cannot manage, caused by the drug's dopamine-like effect on self-control. [1] Examples include: [1]
Gambling (see gambling disorder)
Compulsive shopping
Hypersexuality
Extreme, insatiable hunger (polyphagia)
Excessive engagement with hobbies
In a large study of people with Parkinson's disease, 17.1% of dopamine agonist users had at least one of these disorders, versus 6.9% of non-users. [2] Rates were similar for pramipexole and ropinirole. [2]
What is dopamine agonist withdrawal syndrome?
Dopamine agonist withdrawal syndrome (DAWS) is a reaction that can happen when someone suddenly stops a dopamine agonist or suddenly lowers the dose. [1] It affects roughly 15% to 20% of people who make an abrupt change. [1][4] Researchers are still studying it, but the evidence that it happens is strong. [1]
Symptoms of DAWS include: [1]
Anxiety and panic attacks
Agitation
Excessive sweating (diaphoresis)
Fatigue
Pain
Nausea
Orthostatic hypotension
Who is most at risk of DAWS?
Three factors raise the risk of DAWS: a higher dopamine agonist dose, an impulse control disorder that started while on the drug, and previous deep brain stimulation for Parkinson's disease. [1][4] The more factors a person has, the higher the risk: [1][4]
Number of risk factors | Chance of developing DAWS |
None | 3% |
One | 30% |
Two | 70% |
All three | 92% |
Who should not take dopamine agonists?
Dopamine agonists are not suitable for everyone. Doctors call these reasons "contraindications." [1]
Situation | Why it matters |
Pregnancy or breastfeeding | These drugs can interfere with milk production (lactation) |
High blood pressure | Some dopamine agonists can raise blood pressure further |
Risk of fibrosis | Ergot-based drugs make scar-tissue conditions such as pulmonary fibrosis more likely |
Kidney or liver disease | These organs help clear the drug; disease or failure makes that harder |
Taking MAOI medicines | Some MAOI combinations can be risky, but MAO-B inhibitors such as rasagiline are often used with dopamine agonists for Parkinson's; ask your doctor |
History of psychosis | The risk of psychosis symptoms is much higher in people with this history |
How long can you stay on dopamine agonists?
You can usually stay on dopamine agonists for years, but the risk of some side effects grows the longer you take them. [1]
Can you work or drive while taking dopamine agonists?
Whether you can work or drive safely on a dopamine agonist depends on why you take it, which drug you take and other personal factors. [1] Sleep attacks and daytime sleepiness are possible, especially with pramipexole and ropinirole, so ask your healthcare provider whether driving is safe for you. [1]
How are dopamine agonists different from dopamine and levodopa?
Dopamine agonists differ from dopamine itself because they can enter the brain directly and act there without causing dopamine's body-wide effects. [1]
Feature | Dopamine (as a drug) | Levodopa | Dopamine agonists |
Crosses the blood-brain barrier | No | Yes, then converts to dopamine | Yes, works directly |
Side effects | Effects throughout the body | Severe at higher doses | More common at higher doses and with long-term use |
Long-term use | — | Needs higher doses over time | Can treat Parkinson's earlier, delaying the start of levodopa |
The blood-brain barrier is a protective, filter-like layer around blood vessels in the brain. Dopamine cannot pass it, so the brain makes its own dopamine from other molecules. [1][6]
Levodopa is the main Parkinson's treatment later in life, but its doses must rise over time. Starting with a dopamine agonist earlier can delay levodopa, and taking both together can give a stronger effect at a lower levodopa dose. [1][6]
How do dopamine agonists make you feel?
Dopamine agonists affect people differently: some feel no change, while others notice dizziness or nausea. [1] Some people feel nothing at first and notice changes only after long-term use. [1] A small number may feel euphoria or mania-like highs, but this is not common. [1]
Are dopamine agonists used for depression?
Dopamine agonists are not officially approved in the U.S. to treat depression. [1] Research on pairing them with antidepressants is still early. One small randomized trial of 39 people found that combining pramipexole with escitalopram was no more effective than either drug alone and was harder to tolerate. [5] More research is needed.
Conclusion
Dopamine agonists are medicines that mimic dopamine, and they are among the most important tools for treating Parkinson's disease, especially early on. [1] They also treat restless legs syndrome, high prolactin and several other conditions, and they can help delay higher doses of levodopa. [1]
Their benefits come with real risks. Watch for impulse control changes, sleepiness and mood shifts, and never stop or cut your dose on your own — sudden changes can cause withdrawal. [1][4]
Take this guide to your next appointment. Use the side-effect and risk-factor tables to ask your doctor which dopamine agonist fits your situation, what to watch for and how any dose change will be handled safely. To learn more, read our guides to Parkinson's disease medications, prolactinoma and restless legs syndrome.
FAQ
What do dopamine agonists do?
Dopamine agonists activate dopamine receptors, so cells respond as if dopamine were present. This helps make up for low dopamine activity in conditions such as Parkinson's disease.
What are examples of dopamine agonists?
Common dopamine agonists include pramipexole, ropinirole, rotigotine, apomorphine, fenoldopam, bromocriptine and cabergoline. Amantadine is a different Parkinson's medicine, not a dopamine agonist. Bromocriptine and cabergoline are older ergot-based drugs; the rest are non-ergot.
What conditions do dopamine agonists treat?
Dopamine agonists mainly treat Parkinson's disease, restless legs syndrome and high prolactin. They are also used for neuroleptic malignant syndrome, hypertensive crisis, type 2 diabetes and missing or infrequent periods.
What are the most common side effects of dopamine agonists?
The most common side effects are nausea, vomiting, constipation, dizziness, headaches and lightheadedness on standing. They become more likely as the dose increases.
Can dopamine agonists cause gambling or compulsive behavior?
Yes. Dopamine agonists can cause impulse control problems such as gambling, compulsive shopping, binge eating and hypersexuality. In one large study, 17.1% of users with Parkinson's disease had such a disorder, versus 6.9% of non-users.
What happens if you stop a dopamine agonist suddenly?
Stopping suddenly can cause dopamine agonist withdrawal syndrome, with anxiety, panic, sweating, fatigue, pain and nausea. It affects about 15% to 20% of people who stop or cut their dose abruptly.
Who should not take dopamine agonists?
People who are pregnant or breastfeeding, have high blood pressure, kidney or liver disease, a history of psychosis, or take certain other medicines may need extra care with them. Ergot-based types are avoided when fibrosis risk is high.
Can you drive while taking dopamine agonists?
It depends on your condition, the drug and your response to it. Sleep attacks are possible, especially with pramipexole and ropinirole, so ask your healthcare provider before driving.
Can dopamine agonists cause swelling in the legs?
Yes. Swelling in the ankles or legs is a known side effect. Tell your provider if it happens, and get care right away if swelling comes with shortness of breath.
Can dopamine agonists cause hallucinations?
Yes, especially in older adults and people with Parkinson's disease. Tell your provider if you see or hear things that aren't there, because a dose change may help.
Related Reading
Parkinson's Disease Medications: A Comprehensive Guide to Treatment Options compares the main medicines used to treat Parkinson's disease.
What Is Restless Legs Syndrome? A Plain-Language Guide to the Urge to Move Your Legs at Night explains restless legs syndrome symptoms, causes and treatment.
Understanding Hyperprolactinemia (High Prolactin) explains the causes, symptoms and treatment of high prolactin levels.
Impulse Control Disorders: Understanding the Struggle with Self-Regulation describes impulse control problems and how they are treated.
References
Cleveland Clinic. Dopamine Agonist: What It Is, Uses, Side Effects & Risks. Cleveland Clinic. Last updated May 9, 2023. https://my.clevelandclinic.org/health/treatments/24958-dopamine-agonists
Weintraub D, Koester J, Potenza MN, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Archives of Neurology. 2010;67(5):589-595. PMID: 20457959. https://doi.org/10.1001/archneurol.2010.65
Soileau LG, Talbot NC, Storey NR, et al. Impulse control disorders in Parkinson's disease patients treated with pramipexole and ropinirole: a systematic review and meta-analysis. Neurological Sciences. 2024;45(4):1399-1408. PMID: 38079019. https://doi.org/10.1007/s10072-023-07254-1
Garcia X, Mohammad ME, Patel S, et al. Dopamine agonist withdrawal syndrome associated factors: A retrospective chart review. Clinical Parkinsonism & Related Disorders. 2022;7:100153. PMID: 35909701. https://doi.org/10.1016/j.prdoa.2022.100153
Franco-Chaves JA, Mateus CF, Luckenbaugh DA, et al. Combining a dopamine agonist and selective serotonin reuptake inhibitor for the treatment of depression: a double-blind, randomized pilot study. Journal of Affective Disorders. 2013;149(1-3):319-325. PMID: 23517885. https://doi.org/10.1016/j.jad.2013.02.003
Choi J, Horner KA. Dopamine agonists. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; updated June 26, 2023. NCBI Bookshelf ID: NBK551686. https://www.ncbi.nlm.nih.gov/books/NBK551686/
Bhatia A, Lenchner JR, Saadabadi A. Biochemistry, dopamine receptors. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; updated June 22, 2023. NCBI Bookshelf ID: NBK538242. https://www.ncbi.nlm.nih.gov/books/NBK538242/
Sonne J, Goyal A, Patel P. Dopamine. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; updated April 9, 2026. NCBI Bookshelf ID: NBK535451. https://www.ncbi.nlm.nih.gov/books/NBK535451/
Medical disclaimer
This article is for general education and does not replace professional medical advice, diagnosis or treatment. Do not start, stop or change the dose of any medicine without talking to your doctor or pharmacist. If you have a medical emergency, contact your local emergency services right away.
Comments